COVID-19 complications in males and females: recent developments
Journal of Comparative Effectiveness Research, ISSN: 2042-6313, Vol: 11, Issue: 9, Page: 689-698
2022
- 27Citations
- 66Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations27
- Citation Indexes27
- 27
- CrossRef4
- Captures66
- Readers66
- 66
- Mentions1
- News Mentions1
- 1
Most Recent News
Differences in COVID-19 outcomes related to sex
Coronavirus disease 2019 (COVID-19) has caused approximately 386 million cases worldwide, 138 million cases in the United States, 5.7 million deaths worldwide, and over 888,000 deaths
Review Description
Aim: To provide a comprehensive understanding of the varying effects of SARS-CoV-2 infection based on sex. Methods: A PubMed search of 470 primary articles was performed, with inclusion based on relevance (sex differences discussed in the target COVID population) and redundancy. PubMed was queried based on title for the keywords "SEX"and "COVID"or "SARS"between 2020 and 2022. Results: For COVID-19, males have increased risk for infectivity and intensive care unit admission and worse overall outcomes compared with females. Genetic predispositions, sex hormones, immune system responses and non-biological causes all contribute to the disparity in COVID-19 responses between the sexes. COVID-19 sex-related determinants of morbidity and mortality remain unclear. Conclusions: Male sex is a risk factor for several overall worse outcomes related to COVID-19. Investigating the sex impact of COVID-19 is an important part of understanding the behavior of the disease. Future work is needed to further explore these relationships and optimize the management of COVID-19 patients based on sex.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85130889147&origin=inward; http://dx.doi.org/10.2217/cer-2022-0027; http://www.ncbi.nlm.nih.gov/pubmed/35510532; https://becarispublishing.com/doi/10.2217/cer-2022-0027; https://dx.doi.org/10.2217/cer-2022-0027; https://www.futuremedicine.com/doi/10.2217/cer-2022-0027
Becaris Publishing Limited
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know